CRISPR QC, a start-up company based in San Diego, has raised  $1.6 million in a seed funding round led by Serra Ventures. The company is expected to use the funding to advance the commercial development of its CRISPR Analytics Platform, which is able to directly measure CRISPR activity, providing users with data and insights to improve the level of precision achievable in genome engineering. The platform is built on CRISPR-Chip, a technology reportedly capable of uncovering real-time insights into the biochemical factors that drive gene-editing success.